Tactile Systems Technology, Inc. reported a 20% increase in total revenue for Q4 2022, reaching $73.9 million compared to $61.7 million in Q4 2021. The company also saw improvements in profitability, with operating income increasing to $7.9 million and net income reaching $4.6 million, a significant turnaround from the net loss of $7.5 million in the same quarter of the previous year.
Total revenue increased 20% year-over-year to $73.9 million.
Lymphedema products revenue increased 14% year-over-year to $65.8 million.
Airway clearance products revenue increased 90% year-over-year to $8.1 million.
Net income was $4.6 million, a significant increase from the net loss of $7.5 million in Q4 2021.
The Company expects full year 2023 total revenue in the range of $269.0 million to $273.0 million, representing growth of approximately 9% to 11% year-over-year, compared to total revenue of $246.8 million in 2022.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance